Clinical Trial Update: MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection [Phase 2]

View source ↗

Summary

Phase 2 trial comparing MRX-I to linezolid for acute bacterial skin and skin structure infection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infection

Drugs mentioned

• Linezolid (Linezolid)
• MRX-I

Snippet

Sponsor: MicuRx | Conditions: Bacterial Infections | Phase 2 | Status: COMPLETED | Results posted: 2024-11-04